Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
NPJ Systems Biology and Applications|March 7, 2018
Population-based mechanistic modeling allows for quantitative predictions of drug responses across cell typesJingqi Q X Gong, Eric A SobieZhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|September 18, 2018
[Myxoid variant of angiomatoid fibrous histiocytoma: a clinicopathologic analysis of 3 cases]Q X Gong, Z H Zhang, Q H FanZhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|February 13, 2018
[Pulmonary microcystic fibromyxoma: report of a case with review of literature]Q X Gong, H Li, Z H Zhang, et al.Journal of Molecular and Cellular Cardiology|December 16, 2020
The role of β-adrenergic system remodeling in human heart failure: A mechanistic investigationMaria T Mora, Jingqi Q X Gong, Eric A Sobie, et al.Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|October 29, 2023
[Primary hepatic angiosarcoma: a clinicopathological analysis of nine cases]S Zhao, Y Zhu, S Y Ma, et al.Journal of Molecular and Cellular Cardiology|April 25, 2020
Quantitative analysis of variability in an integrated model of human ventricular electrophysiology and β-adrenergic signalingJingqi Q X Gong, Monica E Susilo, Anna Sher, et al.Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|January 25, 2025
[Advances in the pathology of soft tissue in China over the past ten years: retrospect and prospect]X C Yan, A J Han, H Y Zhang, et al.Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|September 6, 2023
[Malignant peripheral nerve sheath tumor: a clinicopathological analysis]W Peng, Q X Gong, Q H Fan, et al.Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|January 12, 2018
[Clinicopathologic features of primary hepatic marginal zone lymphoma of mucosa-associated lymphoid tissue and hepatic pseudolymphoma]C Liu, X Li, H Li, et al.Journal of Clinical Pharmacology|April 14, 2023
Pooled Population Pharmacokinetic Analyses of Venetoclax in Patients Across Indications and Healthy Subjects from Phase 1, 2, and 3 Clinical TrialsJingqi Q X Gong, Ahmed A Suleiman, Rajeev Menon, et al.Pageof 3